Assignee
RETROPHIN INC
US·7 granted patents·4 pending applications·8 citations·filing 2013–2020
Top patents by PatentIndex Score
11 records- 0175US9181286B2Pantothenate derivatives for the treatment of neurologic disordersRETROPHIN INC·Filed 2014·Granted Nov 10, 2015·3 cites·19 claims
- 0275US8673883B2Pantothenate derivatives for the treatment of neurologic disordersRETROPHIN INC·Filed 2013·Granted Mar 18, 2014·3 cites·26 claims
- 0370US10864197B2Biphenyl sulfonamide compounds for the treatment of kidney diseases or disordersRETROPHIN INC·Filed 2020·Granted Dec 15, 2020·1 cites·18 claims
- 0467US9896464B2Pantothenate derivatives for the treatment of neurological disordersRETROPHIN INC·Filed 2014·Granted Feb 20, 2018·1 cites·18 claims
- 0556US2021196688A1Biphenyl sulfonamide compounds for the treatment of kidney diseases or disordersRETROPHIN INC·Filed 2020·Application pending·0 cites
- 0652US10407447B2Pantothenate derivatives for the treatment of neurological disordersRETROPHIN INC·Filed 2018·Granted Sep 10, 2019·0 cites·14 claims
- 0751US9629862B2Pantothenate derivatives for the treatment of neurologic disordersRETROPHIN INC·Filed 2015·Granted Apr 25, 2017·0 cites·16 claims
- 0845US2019262317A1Biphenyl sulfonamide compounds for the treatment of kidney diseases or disordersRETROPHIN INC·Filed 2017·Application pending·0 cites
- 0943US2020121604A1Solid fosmetpantotenate formulationsRETROPHIN INC·Filed 2018·Application pending·0 cites
- 1037US10364263B2Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disordersRETROPHIN INC·Filed 2016·Granted Jul 30, 2019·0 cites·22 claims
- 1136US2019337971A1Pantetheine derivatives for the treatment of neurologic disordersRETROPHIN INC·Filed 2017·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →